WallStreetZenWallStreetZen

NYSE: CTLT
Catalent Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CTLT

Based on 6 analysts offering 12 month price targets for Catalent Inc.
Min Forecast
$42.00-24.73%
Avg Forecast
$55.42-0.69%
Max Forecast
$63.50+13.8%

Should I buy or sell CTLT stock?

Based on 6 analysts offering ratings for Catalent Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 16.67%
Hold
5 analysts 83.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CTLT stock forecasts and price targets.

CTLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-04
lockedlocked$00.00+00.00%2024-02-20
lockedlocked$00.00+00.00%2024-02-06
lockedlocked$00.00+00.00%2024-01-25
lockedlocked$00.00+00.00%2023-11-16
Baird
Top 20%
81
BuyUpgrades$53.00-5.02%2023-11-16

1 of 1

Forecast return on equity

Is CTLT forecast to generate an efficient return?
Company
N/A
Industry
0.07%
Market
19.16%

Forecast return on assets

Is CTLT forecast to generate an efficient return on assets?
Company
N/A
Industry
0.04%

CTLT revenue forecast

What is CTLT's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$4.4B+6.72%
Avg 2 year Forecast
$4.7B+13.96%
Avg 3 year Forecast
$5.0B+22.62%
CTLT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CTLT revenue growth forecast

How is CTLT forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
6.97%
Industry
10.2%
Market
9.03%
CTLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CTLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CTLT vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
CTLT$55.80$55.42-0.69%Hold
RDY$74.02$80.00+8.08%Strong Buy
ITCI$72.13$94.20+30.60%Strong Buy
VTRS$11.47$13.00+13.34%Hold
NBIX$137.76$144.65+5.00%Buy
View Top Pharmaceutical Stocks

Catalent Stock Forecast FAQ

Is Catalent Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: CTLT) stock is to Hold CTLT stock.

Out of 6 analysts, 0 (0%) are recommending CTLT as a Strong Buy, 1 (16.67%) are recommending CTLT as a Buy, 5 (83.33%) are recommending CTLT as a Hold, 0 (0%) are recommending CTLT as a Sell, and 0 (0%) are recommending CTLT as a Strong Sell.

If you're new to stock investing, here's how to buy Catalent stock.

What is CTLT's revenue growth forecast for 2024-2026?

(NYSE: CTLT) Catalent's forecast annual revenue growth rate of 6.97% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 10.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.

Catalent's revenue in 2024 is $4,098,000,000.On average, 7 Wall Street analysts forecast CTLT's revenue for 2024 to be $790,455,317,924, with the lowest CTLT revenue forecast at $783,779,771,898, and the highest CTLT revenue forecast at $795,343,368,345. On average, 7 Wall Street analysts forecast CTLT's revenue for 2025 to be $844,028,314,384, with the lowest CTLT revenue forecast at $837,624,597,821, and the highest CTLT revenue forecast at $850,898,514,886.

In 2026, CTLT is forecast to generate $908,167,416,062 in revenue, with the lowest revenue forecast at $890,418,976,377 and the highest revenue forecast at $924,173,183,085.

What is CTLT's forecast return on assets (ROA) for 2024-2026?

(NYSE: CTLT) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.04%.

What is CTLT's Price Target?

According to 6 Wall Street analysts that have issued a 1 year CTLT price target, the average CTLT price target is $55.42, with the highest CTLT stock price forecast at $63.50 and the lowest CTLT stock price forecast at $42.00.

On average, Wall Street analysts predict that Catalent's share price could fall to $55.42 by Apr 4, 2025. The average Catalent stock price prediction forecasts a potential downside of 0.69% from the current CTLT share price of $55.80.

What is CTLT's forecast return on equity (ROE) for 2024-2026?

(NYSE: CTLT) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.